BULLETIN OF THE
Article
Asymmetric Synthesis of Two Regioisomeric 1,4-Benzoxazinones
KOREAN CHEMICAL SOCIETY
tR (R-enantiomer) = 20.1 min; HRMS: calcd. for C19H22NO2
[M+ + 1] 296.1651; found 296.1651.
Acknowledgments.
This work was supported by
Basic Science Research Program funded by the National
Research Foundation of Korea under Grant No. NRF-
2020R1F1A1049676.
4-Allyl-6-methyl-3-Oxo-2-phenyl-3,4-dihydro-2H-
1,4-benzoxazine (3e). A pale yellow oil, 68% yield from 1a;
1H NMR (400 MHz, CDCl3) 7.34–7.28 (m, 5H), 6.96–6.72 (m,
3H), 5.94–5.84 (m, 1H), 5.73 (s, 1H), 5,21–5.12 (m, 2H),
4.76–4.70 (m, 1H), 4.45–4.40 (m, 1H), 2.27 (s, 3H); 13C NMR
(100 MHz, CDCl3) 164.6, 141.8, 135.3, 132.3, 131.6, 128.6,
128.5, 128.2, 126.7, 124.5, 117.3, 117.1, 115.9, 78.4, 44.1,
21.1; CSP-HPLC (Chiralcel OD column; 10% isopropanol in n-
hexane; 0.5 mL/min): 90:10 er, tR (S-enantiomer) = 13.0 min; tR
(R-enantiomer) = 15.1 min; HRMS: calcd. for C18H18NO2
[M++1] 280.1338; found 280.1341.
Conflict of interest. The authors declare no conflict of
interest.
Supporting Information. Additional supporting informa-
tion is available in the online version of this article. The
NMR spectra of new compounds 2d, 2f, 2h, 3b, 3c, 3d, 3e,
4a and 5 and the CSP-HPLC chromatograms.
6-Methyl-3-oxo-2-phenyl-3,4-dihydro-2H-
References
1,4-benzoxazine (3f). A colorless oil, 59% yield from 5;
1
Known compound, ref. 3b,7a; H NMR (400 MHz, CDCl3)
1. (a) F. A. Macías, D. Marín, A. Oliveros-Bastidasab, J. M. G.
Molinillo, Nat. Prod. Rep. 2009, 26, 478.(b) J. Ilaš, P. Š.
Anderluh, M. S. Dolenc, D. Kikelj, Tetrahedron 2005, 61,
7325. (c) D. A. Dudley, A. M. Bunker, L. Chi, W. L. Cody,
D. R. Holland, D. P. Ignasiak, N. Janiczek-Dolphin, T. B.
McClanahan, T. E. Mertz, L. S. Narasimhan, S. T. Rapundalo,
J. A. Trautschold, C. A. Van Huis, J. J. Edmunds, J. Med.
Chem. 2000, 43, 4063. (d) A. N. Matralis, M. G. Katselou, A.
Nikitakis, A. P. Kourounakis, J. Med. Chem. 2011, 54, 5583.
2. For asymmetric synthesis of 1,4-benzoxazin-2-ones, see (a) J. L.
Núñez-Rico, A. Vidal-Ferran, Org. Lett 2013, 15, 2066. (b) Q.-A.
Chen, K. Gao, Y. Duan, Z.-S. Ye, L. Shi, Y. Yang, Y. G. Zhou,
J. Am. Chem. Soc. 2012, 134, 2442. (c) Z.-Y. Xue, Y. Jiang, X.-Z.
Peng, W.-C. Yuan, X.-M. Zhang, Adv. Synth. Catal. 2010, 352,
2132. (d) A. V. Malkov, K. Vranková, S. Stoncˇius, P. Kocˇovský,
J. Org. Chem. 2009, 74, 5839. (e) X. Zhang, B. Xu, M.-H. Xu,
Org. Chem. Front. 2016, 3, 944. (f) C. Huo, J. Dong, Y. Su, J.
Tang, F. Chen, Chem. Comm. 2016, 52, 13341. (g) L. Zhao, J. Wei,
J. Lu, C. He, C. Duan, Angew. Chem. Int. Ed. 2017, 56, 8692. (h)
E. Youk, W. Park, Y. S. Park, Synth. Commun. 2018, 48, 1131.
3. For asymmetric synthesis of 2,2-disubstituted 1,4-benzoxazin-
3-ones, see (a) M. Breznik, V. Hrast, A. Mrcina, D. Kikelj, Tet-
rahedron 1999, 10, 153. (b) M. Pawliczek, Y. Shimazaki, H.
Kimura, K. M. Oberg, S. Zakpur, T. Hashimoto, K. Maruoka,
Chem. Commun. 2018, 54, 7078.
4. (a) K. J. Park, Y. Kim, M. Lee, Y. S. Park, Eur. J. Org. Chem.
2014, 2014, 1645. (b) Y. S. Choi, S. Park, Y. S. Park, Eur.
J. Org. Chem. 2016, 2016, 2539. (c) Y. Kim, Y. S. Choi, S. K.
Hong, Y. S. Park, Org. Biomol. Chem. 2019, 17, 4554. (d) W.
Park, Y. Kim, Y. S. Park, Eur. J. Org. Chem. 2019, 2019, 2671.
5. In references 4, it has been established that (αS)-products were
provided in the substitution of (αR)-1a-c with various nucleo-
philes via SN2 (like) mechanism. The absolute configuration of
2a, 2b, 2c, 2e, 2g, 2i, 2j and 3a is confirmed to be (S) by com-
parison of CSP-HPLC retention time with previously reported
data (refs. 2h and 6). The absolute configuration of 2d, 2f, 2h
and 3b-f is assigned by analogy.
7.47–7.33 (m, 5H), 6.91–6.65 (m, 3H), 5.68 (s, 1H), 2.24
(s, 3H); 13C NMR (100 MHz, CDCl3) 166.9, 140.5, 135.1,
132.5, 129.0, 128.8, 127.1, 125.5, 125.0, 117.0, 116.6,
78.4, 20.8; CSP-HPLC (Chiralcel OJ-H column; 40%
isopropanol in n-hexane; 0.5 mL/min): 93:7 er, tR
(S-enantiomer) = 19.8 min; tR (R-enantiomer) = 17.3 min.
General Procedure for the Preparation of 4a and 5. To
a solution of α-bromo-α-phenylacetate 1a of 99:1 dr (1.0
equiv) at ambient temperature were added N-Boc-
2-aminophenol (10 equiv) and AgOTf (1.0 equiv). After
the reaction mixture was stirred for 3 h, the resulting mix-
ture was treated with extractive work up and the solvent
was evaporated. The crude mixture was purified by column
chromatography on silica gel to afford the product.
N-Benzoyl-O-[α-(N-Boc-3-amino-4-hydroxyphenyl)
phenylacetyl]-L-threonine Isopropyl Ester (4a). A yellow
1
oil, 99:1 dr, 80% yield from 1a; H NMR (400 MHz, CDCl3)
7.53–7.34 (m, 10H), 7.09–7.07 (m, 1H), 7.01–6.97 (m, 2H),
6.74–6.70 (m, 1H), 6.49–6.47 (m, 1H), 5.52–5.47 (m, 1H),
5.09–4.93 (m, 4H), 1.52 (s, 9H), 1.23 (d, J = 6.0 Hz, 3H), 1.11 (d,
J = 6.4 Hz, 3H), 1.04 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz,
CDCl3) 170.4, 169.0, 168.1, 151.6, 138.4, 138.0, 136.9, 133.7,
132.0, 129.1, 128.5, 127.4, 127.2, 121.9, 118.0, 112.7, 84.2, 73.1,
70.0, 60.8, 55.7, 27.6, 21.8, 21.5, 16.3; HRMS: calcd. for
C33H39N2O8 [M++1] 591.2706; found 591.2705.
N-Benzoyl-O-[α-(N-Boc-2-amino-4-methylphenoxy)
phenylacetyl]-L-threonine Isopropyl Ester (5). A yellow
1
oil, 20% yield from 1a; H NMR (400 MHz, CDCl3) 7.94
(br, 1H), 7.72–7.70 (m, 2H), 7.55–7.20 (m, 8H), 6.86–6.82
(m, 1H), 6.67–6.57 (m, 2H), 5.57 (s, 1H), 5.54–5.48 (m,
1H), 5.00–4.86 (m, 2H), 2.24 (s, 3H), 1.50 (s, 9H), 1.22 (d,
J = 6.0 Hz, 3H), 1.18 (d, J = 6.4 Hz, 3H), 0.97 (d,
J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) 169.0,
168.9, 167.8, 152.9, 143.6, 134.9, 133.5, 132.5, 132.1,
129.4, 129.0, 128.7, 128.6, 128.5, 127.2, 127.1, 127.0,
122.8, 119.7, 113.0, 80.5, 79.9, 72.8, 70.2, 55.8, 28.3,
21.8, 21.3, 21.1, 16.6; HRMS: calcd. For C34H41N2O8
[M++1] 605.2863; found 605.2866.
6. K. E. O. Ylijoki, E. P. Kündig, Chem. Commun. 2011, 47, 10608.
7. (a) J. W. Park, S. Jang, M. H. Choo, D. Y. Kim, Bull. Korean.
Chem.Soc. 2020, 41, 570. (b) M. Pawliczek, Y. Shimazaki, H.
Kimura, K. M. Oberg, S. Zakpur, T. Hashimoto, K. Maruoka,
Chem. Comm. 2018, 54, 7078.
Bull. Korean Chem. Soc. 2020
© 2020 Korean Chemical Society, Seoul & Wiley-VCH GmbH
6